Dr. Michael Rafii, our clinical director, is launching a Down Syndrome Biomarker Initiative to help shed light on Alzheimer's Disease prevention in people with Down syndrome, and ultimately to help the general population as well.
Two of our researchers,
Pavel Belichenko and
Alexander Kleschevnikov, wrote a chapter:
Deficiency of Adult Neurogenesis in the Ts65Dn Mouse Model of Down Syndrome for a new book:
Genetics and Etiology of Down Syndrome.
Scientists at Dana-Farber Cancer Institute in Boston have demonstrated a potential link between cancerous cell growth and the cognitive deficits caused by Down syndrome.
Check back for information about new research related to Down syndrome.
research published by members of our team.